We use cookies to give you the best possible experience on our website.

NICE Implementation Collaborative (NIC)
 

The NIC is a unique partnership between the NHS, Life Sciences industry, Healthcare professional bodies, key health organisations and Patient groups. NIC partners are committed to working together to support a system where patients have faster and more consistent access to NICE-recommended medicines, treatments and technologies and is a collaboration which completely re-draws the landscape. Industry will now work with academia, clinical groups, NHS England, NICE and representative bodies to drive compliance with NICE recommendations.

The partnership underpinned by the signing of a concordat in March 2013. The Concordat is made up of the following members:

  • Academy of Medical Royal Colleges
  • Association of British Healthcare Industries (ABHI)
  • Foundation Trust Network
  • NHS Alliance NHS
  • Commissioning Assembly
  • NHS Confederation
  • NHS England
  • National Institute for Health and Care Excellence (NICE)
  • Patients Involved in NICE
  • Royal Pharmaceutical Society
  • The Academy of Medical Sciences
  • The Association of the British Pharmaceutical Industry (ABPI)
  • The British In Vitro Diagnostics Association (BIVDA)

What does the NIC do?

  1. Identify practical measures that support and promote timely and consistent implementation of NICE Technology Appraisals throughout the NHS in England
  2. Work jointly to support and promote the adoption of all other forms of NICE guidance that apply to the NHS in England, and to drive the uptake of innovation, in a way that is consistent with local health needs and priorities
  3. Understand the barriers that restrict expected levels of implementation and uptake, including the requirement for CCGs to provide care for their populations taking into account local affordability and clinical need. The NIC will identify practical measures that its members and all organisations providing NHS services to patients can take to help overcome these barriers
  4. Support a culture shift within the NHS in favour of clinically- and cost-effective innovation

 

Small arrow Latest NIC work streams

Nalmefene (NICETA 325)

Nalmefene (NICE TA 325) for reducing alcohol consumption in people with alcohol dependance. The NIC currently has a work stream looking at the implementation...

Non-ST-Elevation Acute Coronary Syndromes

Improving NSTEACS patient outcomes and experience. The 2013 Cardiovascular Outcomes Strategy report highlighted that there is scope for improvement in the...
Small arrow Recent NIC work streams
Back

Insulin Pumps (NICE TA 151)

Small arrow Insulin Pumps are a proven way to reduce the long-term complications for patients with Type 1 Diabetes. They are small portable devices that provide precise dosing, giving patients a controlled and steady infusion of insulin, rather than the intermittent and larger ones they receive with multiple daily injections.

NICE recommends the use of Insulin Pump Therapy for some people with Type 1 Diabetes and suggest that the this treatment could benefit 8-15% of adults and up to 50% of children under the age of 12. Uptake of this NICE guidance has historically been low and in many areas less than 1% of patients who may benefit have been given a pump. The NIC will examine this area to see what steps need to be taken to improve patient access to this technology. The pilot will build on a project already run with the NHS Technology Adoption Centre in which Birmingham Children’s Hospital NHS Foundation Trust successfully implemented NICE guidance across one geographical area.

Critical barriers to overcome

• Absence of any coherent funding and approvals process across a number of commissioning organisations

• Difficulty in compiling a business case that secures the resources against competing priorities

• Gathering all relevant and critical information in one place

• Finding successful ways to engage with patients and their families, so that the service meets their needs

How can NIC help overcome these barriers?

From the earlier work in Birmingham, we know that it is possible to overcome these acritical barriers by:

  • Developing a single funding and approvals process across a commissioning organisations
  • Developing a business case template to help organisations secure the resources to deliver the service
  • Assembling all of the relevant information for managers and clinical staff in one place to support the delivery of staff training, boost confidence and motivation
  • Spreading learning on how to engage with patients and their families to make sure the service meets their needs, including the education and advice that are needed.

Uptake of Insulin Pumps continues to be slow. To “ramp up the pace and scale of change and innovation ”, this NIC pilot will focus on rolling out what has already been learned to enable every NHS organisation to implement NICE Guidance (TA 151) and give appropriate patient groups access to the technology. This is expected to sit alongside work to develop the experimental innovation scorecard, recently published by another Innovation, Health & Wealth project.
 



No comments yet. Be the first.
Small arrow Relevant NIC documents

Innovation Scorecard - Challenging Variation Report

Many of the medicines and medical technologies reviewed by the NIC are included in the quarterly Innovation Scorecard publication. The NHS England Innovation team produce a quarterly summary...

NICE Implementation Collaborative Concordat

Click here to download a copy of the NICE Implementation Collaborative Concordat which was signed by NIC partners in 2013.

Getting cost effective technologies into practice

This draft report produced for the NIC looks at a framework to assess the value to the NHS of investing in the implementation of NICE technologies. The report looks how the model could be applied...

Other relevant initiatives 

Horizontal line

Road map link

Innovation Compass link